Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.65 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9355139 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL585911 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL6055738 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197196 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2193814 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4304542 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2193820 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2196655 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4903660 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL15419872 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | claimed |
| US-11395823-B2 | Topical administration of MEK inhibiting agents for the treatment of skin disorders | DUKE UNIVERSITY (US) | 2022-07-26 | — | — | US | claimed |
| US-20210308145-A1 | Pharmaceutical Composition | FCB I LLC (US) | 2021-10-07 | — | — | US | claimed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| CN-107257844-B | Synergistic perfuming composition | 弗门尼舍有限公司 | 2021-09-14 | — | — | CN | claimed |
| US-20210060018-A1 | TOPICAL ADMINISTRATION OF MEK INHIBITING AGENTS FOR THE TREATMENT OF SKIN DISORDERS | DUKE UNIVERSITY | 2021-03-04 | — | — | US | claimed |
| EP-2844065-B1 | LURE COMPOSITION | ATTRATEC GMBH (DE) | 2021-01-06 | — | — | EP | claimed |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2020-11-05 | — | — | US | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| EP-0975622-B1 | SELECTIVE OLEFIN METATHESIS OF BIFUNCTIONAL OR POLYFUNCTIONAL SUBSTRATES IN COMPRESSED CARBON DIOXIDE AS REACTION MEDIUM | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-10-09 | — | — | EP | claimed |
| US-6379658-B1 | CONSISTING OF BETA-NAPHTHYL METHYL ETHER, BETA-NAPHTHYL KETONE, BENZYL ACETONE, HEXAHYDRO-4,7-METHANOINDEN-5-YL AND 6-YL PROPIONATES, GAMMA-METHYL IONONE, FURAN DERIVATIVE, 3,7-DIMETHYL-2,6-NONADIEN-1-NITRILE, CYCLIC ESTER, KETONE | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2002-04-30 | — | — | US | claimed |
| US-6348551-B1 | CATALYTIC CYCLIZATION OF ALKENES AND ALKYNES; ESTERIFICATION, LACTONIZATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-02-19 | — | — | US | claimed |
| EP-1113105-A2 | Human sweat malodor counteractant composition and process for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2001-07-04 | — | — | EP | claimed |
| US-6057372-A | CONSISTING OF MACROCYCLIC LACTONES OR MACROCYCLIC KETONES; BODY DEODORIZERS, SUPPRESSION OF PIMPLES | SODA AROMATIC CO., LTD. (JP) | 2000-05-02 | — | — | US | claimed |
| EP-0855180-A1 | ANTIBACTERIAL AGENTS AND COSMETICS AND CLOTHES CONTAINING THE SAME | SODA AROMATIC COMPANY, LIMITED (JP) | 1998-07-29 | — | — | EP | claimed |
| US-4335261-A | Process for purifying macrocyclic ketones | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | TRIM24 4153/4885TRIM33 4017/4885ALDH1A1 397/4885 |
| US-20210308145-A1 | Pharmaceutical Composition | NR5A1, SHBG, CYP17A1 | TRIM24 2789/4885TRIM33 4639/4885ALDH1A1 4174/4885 |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | TRIM24 4739/4885TRIM33 3268/4885ALDH1A1 831/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | TRIM24 4739/4885TRIM33 3268/4885ALDH1A1 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.